CrossRefPubMed 8. Passik SD,
Kirsh KL, Theobald DE, Dicherson P, Trowbridge R, Gray D, Beaver M, Comparet J, Brown J: A retrospective chart review of the use of olanzapine for the prevention of delayed emesis in cancer patients. J Pain Symptom Selleck FK506 Manage 2003, 25: 485–488.CrossRefPubMed 9. Passik SD, Navari RM, Jung SH, Nagy C, Vinsor J, Kirsh KL, Loehrer P: A phase I trial of olanzapine (Zyprexa) for the prevention of delayed emesis in cancer patients: a Hoosier Oncology Group study. Cancer Invest 2004, 22: 383–388.CrossRefPubMed 10. Navari RM, Einhorn LH, Passik SD, Loehrer PJ Sr, Johnson C, Mayer ML, McClean J, Vinson J, Pletcher W: A phase II trial of olanzapine for the prevention of chemptherapy-induced nausea and vomiting: a Hoosier Oncology Group study. Support Care Cancer 2005, 13: 529–534.CrossRefPubMed
11. Herrestedt J, koeller JM, Roilla F, Hesketh PJ, Warr D, Rittenberg C, Dicato M: Acute emesis: moderately emetogenic chemotherapy. Support Care Cancer BYL719 mw 2005, 13: 97–103.CrossRef 12. Kris MG, Hesketh PJ, Herrstedt J, Rittenberg C, Einhorn LH, Grunberg S, Koeller J, Olver I, Borjeson S, Ballatori E: Consensus proposals for the prevention of acute and delayed vomiting and nausea following high-emetic-risk chemotherapy. Support Care Cancer 2005, 13: 85–96.CrossRefPubMed 13. American Society of Clinical Oncology, Kris MG, Hesketh PJ, Somerfield MR, Feyer P, Clark-Snow R, Koeller JM, Morrow GR, Chinnery LW, Chesney MJ, Gralla RJ, Grunberg SM: American Society of clinical oncology guideline for antiemetics in oncology: update 2006.
J Clin Oncol 2006, 24: Inositol oxygenase 2932–2947.CrossRefPubMed 14. Roila F, Warr D, Clarck-Snow RA, Tonato M, Gralla RJ, Einhorn LH, Herrstedt J: Delayed emesis: moderately emetogenic chemotherapy. Support Care Cancer 2005, 13: 104–108.CrossRefPubMed 15. Vardy J, Chiew KS, Galica J, Pond GR, Tannock IF: Side effects associated with the use of dexamethasone for prophylaxis of delayed emesis after moderately emetogenic chemotherapy. Br J Cancer 2006, 94: 1011–1015.CrossRefPubMed 16. Dube S, Tollefson GD, Thase ME, Briggs SD, Van Campen LE, Case M, Tohen M: Onset of antidepressant effect of olanzapine and olanzapine/fluoxetine combination in bipolar depression. Bipolar Disord 2007, 9: 618–627.CrossRefPubMed 17. Corya SA, Williamson D, Sanger TM, Briggs SD, Case M, Tollefson G: A randomized, double-blind, comparison of olanzapine/fluoxetine combination, olanzapine, fluoxetine, and venlafaxine in treatment-resistant depression. Depress Anxiety 2006, 23: 364–372.CrossRefPubMed Competing interests The authors declare that they have no competing interests. Authors’ contributions LT designed and carried out this study, drafted the manuscript. DZ conceived of the study, JL participated in its design and modified the manuscript. XL, JC, ZY and HY provided the patients for study. JP, JL and YR helped with the clinical observation. All authors read and approved the final manuscript.